期刊档案 · Biochemistry, Genetics and Molecular Biology-Molecular Medicine
Journal of Cellular and Molecular Medicine
ISSN 1582-4934 · Wiley-Blackwell · United Kingdom
Journal of Cellular and Molecular Medicine 中科院 医学 3区（2025 年升级版），影响因子 4.68，完全开放获取，APC 约 5,730 美元，近 24 个月 108 篇文章投稿到接收中位 153 天，录用比例约50%（社区反馈），2025 年发文 712 篇，SCIE、Scopus 收录，有预警或收录变动提示，请谨慎投稿。
研究范围
研究范围与定位
Journal of Cellular and Molecular Medicine 由 Wiley-Blackwell 出版，属中科院医学大类（2025 升级版3区）。按 OpenAlex 近年发文统计，该刊主要发表 Cancer-related molecular mechanisms research、MicroRNA in disease regulation、RNA modifications and cancer 等主题的论文，这 3 个主题约占 29.8%，主导子领域为 Molecular Biology、Cancer Research。（根据 OpenAlex 主题统计与中科院分区数据生成）
Bridging physiology and cellular medicine, and molecular biology and molecular therapeutics, Journal of Cellular and Molecular Medicine publishes basic research that furthers our understanding of the cellular and molecular mechanisms of disease and translational studies that convert this knowledge into therapeutic approaches. Please note that: Journal of Cellular and Molecular Medicine is online-only. Journal of Cellular and Molecular Medicine joined the Wiley Open Access publishing program of fully open access journals published by Wiley inJanuary 2013. For further information visit the Wiley Open Access website. Open Access and Copyright All articles published in Journal of Cellular and Molecular Medicine are fully open access: immediately freely available to read, download and share. All accepted articles are published under the terms of the Creative Commons Attribution License which permits use, distribution and reproduction in any medium, provided the original work is properly cited. Copyright in any research article published by Journal of Cellular and Molecular Medicine is retained by the author(s). Authors grant Wiley a license to publish the article and identify itself as the original publisher. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified. Read more on Open Access Licence and Copyright here.
摘自期刊官网 Aims & Scope
研究方向（LetPub）：Biochemistry, Genetics and Molecular Biology-Molecular Medicine
主编 Stefan N. Constantinescu出版商官网
编委会国家分布：中国大陆 30 位（约 14%）；主要国家 美国 76、中国 30、罗马尼亚 16、英国 14、德国 11（共 215 位编委标注了国家） 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计，占比为近似值
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology12.1%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology9.8%
- RNA modifications and cancerBiochemistry, Genetics and Molecular Biology7.9%
- Circular RNAs in diseasesBiochemistry, Genetics and Molecular Biology6.7%
- Mesenchymal stem cell researchMedicine4.5%
- Epigenetics and DNA MethylationBiochemistry, Genetics and Molecular Biology4.4%
- Autophagy in Disease and TherapyMedicine4.3%
- Ferroptosis and cancer prognosisMedicine4.1%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）医学 3 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 3 区 |
| 小类 | 细胞生物学CELL BIOLOGY | 3 区 |
| 小类 | 医学：研究与实验MEDICINE, RESEARCH & EXPERIMENTAL | 3 区 |
Top 期刊：否综述期刊：否
《新锐期刊分区表》（ 2026年3月发布）医学 2 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 2 区 |
| 小类 | 细胞生物学CELL BIOLOGY | 3 区 |
| 小类 | 医学：研究与实验MEDICINE, RESEARCH & EXPERIMENTAL | 2 区 |
Top 期刊：否综述期刊：未标注
期刊分区表（ 2023年12月旧的升级版）医学 2 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 2 区 |
| 小类 | 医学：研究与实验MEDICINE, RESEARCH & EXPERIMENTAL | 2 区 |
| 小类 | 细胞生物学CELL BIOLOGY | 3 区 |
Top 期刊：是综述期刊：否
数据库收录
SCIEScopusDOAJLetPub
预警 / 风险提示：2026年03月发布的新锐学术版：不在预警名单中 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：预警等级：中 2020年12月发布的2020版：不在预警名单中LetPub
期刊官网自述收录
Web of ScienceMEDLINEPubMed出版商官网
其他：ProQuest
期刊官网列出的收录清单，未与各数据库逐一核对；Web of Science 各子库以上方记录为准。
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- 影响因子
- 4.68LetPub ·
- CiteScore 2026-06
- 6.9LetPub ·
- SJR 2026-06
- 1.14LetPub ·
- SNIP 2026-06
- 0.92LetPub ·
- h-index
- 108LetPub ·
- h-index
- 187OpenAlex ·
- i10-index
- 6,973OpenAlex ·
- 两年平均被引
- 4.54OpenAlex ·
- 自引率
- 0%LetPub ·
- Gold OA 文章占比
- 100%LetPub ·
发文规模
- 年文章数
- 613LetPub ·
逐年发文量 OpenAlex 统计 · 累计 10,292 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 387 | 387 | 172 |
| 2025 | 712 | 712 | 1,990 |
| 2024 | 795 | 795 | 6,446 |
| 2023 | 486 | 486 | 6,623 |
| 2022 | 531 | 531 | 8,759 |
| 2021 | 946 | 946 | 23,160 |
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
文章统计的审稿周期 Crossref 登记的稿件日期 · 至
153 天投稿到接收中位数 · P25–P75 111 天 – 211 天
- 接收到上线
- 中位数 20 天（108 篇）
- 投稿到上线
- 中位数 187 天
- 样本
- 108 篇有投稿与接收日期的文章（窗口内共 1,250 篇），最近一篇接收于
只统计最终被录用并发表的文章，不含被拒稿件的处理时间，因此通常长于出版商公布的"首次决定时间"。
其他来源
- 平均审稿速度（社区反馈）
- 28 WeeksLetPub ·
- 平均录用比例（社区反馈）
- 50%LetPub ·
- 投稿到发表（期刊自报）
- 约 28 周DOAJ ·
- 评审方式
- 同行评审（未说明方式）DOAJ
社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
完全开放获取DOAJ
所有文章开放获取，通常向作者收取文章处理费（APC）。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| DOAJ | USD 5,730 / GBP 3,720 / EUR 5,310 | 有 | CC BY | |
| OpenAlex | USD 5,210 / EUR 4,830 / GBP 3,380 | — | — | |
| LetPub | USD 4,510 / GBP 2,920 / EUR 4,180 | 有 | — |
- APC 费用说明 ↗DOAJ
- 费用减免政策 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
接收的文章类型12 种，含篇幅限制
- commentaryOriginal Articles (research papers): Cover Letter - The cover letter must include a list of relevant articles published by the corresponding author/most senior …未说明篇幅
- editorialOriginal Articles (research papers): Cover Letter - The cover letter must include a list of relevant articles published by the corresponding author/most senior …未说明篇幅
- letterOriginal Articles (research papers): Cover Letter - The cover letter must include a list of relevant articles published by the corresponding author/most senior …未说明篇幅
- letter to the editorOriginal Articles (research papers): Cover Letter - The cover letter must include a list of relevant articles published by the corresponding author/most senior …未说明篇幅
- opinionOriginal Articles (research papers): Cover Letter - The cover letter must include a list of relevant articles published by the corresponding author/most senior …未说明篇幅
- original articleOriginal Articles (research papers): Cover Letter - The cover letter must include a list of relevant articles published by the corresponding author/most senior …未说明篇幅
- original articlesOriginal Articles (research papers): Cover Letter - The cover letter must include a list of relevant articles published by the corresponding author/most senior …未说明篇幅
- research paperOriginal Articles (research papers): Cover Letter - The cover letter must include a list of relevant articles published by the corresponding author/most senior …未说明篇幅
- reviewOriginal Articles (research papers): Cover Letter - The cover letter must include a list of relevant articles published by the corresponding author/most senior …未说明篇幅
- reviewsReviews: Cover Letter – The cover letter must include a list of relevant articles published by the corresponding/most senior author in the last 3-5 years.未说明篇幅
- short communicationOriginal Articles (research papers): Cover Letter - The cover letter must include a list of relevant articles published by the corresponding author/most senior …正文 ≤ 1,200 词
- short communicationsShort Communications: Cover Letter 1,200 words excluding title page, abstract, references, and figure legends未说明篇幅
官网政策摘录作者资格、利益冲突、数据可用性、出版伦理、许可与版权、开放获取、同行评审、预印本
- 作者资格 Authorship
The list of authors should accurately illustrate who contributed to the work and how. All those listed as authors should qualify for authorship according to the following criteria: Have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; Been involved in drafting the manuscript or revising it critically for important intellectual…
原文 ↗出版商官网 ·- 利益冲突 Conflict of Interest
The journal requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potent…
原文 ↗出版商官网 ·- 数据可用性
Data sharing expected; Data Availability Statement required for all accepted manuscripts. 模型摘要
Data Sharing, Data Availability, and Data Reporting This journal expects data sharing. All accepted manuscripts are required to publish a Data Availability Statement to confirm the presence or absence of shared data.
原文 ↗出版商官网 ·- 出版伦理 5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS
Peer Review and Acceptance The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Once your manuscript has been submitted, the editorial staff will check the formatting of the files to ensure they are in adherence with the above. The Editor-in-Chief (EiC) then evaluates it to check whether it fits with the aims and scope. …
原文 ↗出版商官网 ·- 许可与版权 Open Access and Copyright
All articles published in Journal of Cellular and Molecular Medicine are fully open access: immediately freely available to read, download and share. All accepted articles are published under the terms of the Creative Commons Attribution License which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
原文 ↗出版商官网 ·- 开放获取 Open Access and Copyright
All articles published in Journal of Cellular and Molecular Medicine are fully open access: immediately freely available to read, download and share. All accepted articles are published under the terms of the Creative Commons Attribution License which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
原文 ↗出版商官网 ·- 同行评审 Peer Review and Acceptance
The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Once your manuscript has been submitted, the editorial staff will check the formatting of the files to ensure they are in adherence with the above. The Editor-in-Chief (EiC) then evaluates it to check whether it fits with the aims and scope. Papers will only be sent to…
原文 ↗出版商官网 ·- 预印本
Preprints considered for review; authors may post submitted version to a preprint server at any time. 模型摘要
Preprint policy: Please find the Wiley preprint policy here. The Journal of Cellular and Molecular Medicine will consider for review articles previously available as preprints. Authors may also post the submitted version of a manuscript to a preprint server at any time.
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版商
- Wiley-Blackwell
- 出版国家或地区
- United Kingdom
- 出版语言
- English
- ISSN
- 1582-4934
- 官方链接
- 期刊主页 ↗OpenAlex
- 投稿系统 ↗LetPub
- 作者指南 ↗LetPub
- Aims & Scope ↗DOAJ
- 专刊 / 特刊征稿 ↗出版商官网
- APC 费用说明 ↗DOAJ
- 费用减免政策 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
- 评审流程 ↗DOAJ
- 编委会 ↗DOAJ
- 查重政策 ↗DOAJ
常见问题
关于 Journal of Cellular and Molecular Medicine 的常见问题
Journal of Cellular and Molecular Medicine 是中科院几区期刊？
2025 年升级版分区表中，Journal of Cellular and Molecular Medicine 为医学 3区，小类 细胞生物学 / 医学：研究与实验 3 区。2026 年新锐版分区表中为医学 2区。不同版本与大小类分区不能混用。
Journal of Cellular and Molecular Medicine 的影响因子是多少？
LetPub 汇总的最新公布影响因子为 4.68，CiteScore 为 6.9，h-index 为 187。
Journal of Cellular and Molecular Medicine 的审稿周期多长？
按 2024年10月至2026年10月（近 24 个月）108 篇已发表文章登记的日期，投稿到接收的中位数为 153 天（四分位 111–211 天）；投稿社区反馈的平均审稿速度为约 28 周，平均录用比例反馈为“约50%”。文章统计只含被录用的稿件，出版商数据口径以官网为准，社区反馈来自投稿者样本，均不代表期刊承诺。
Journal of Cellular and Molecular Medicine 的编委会里有中国学者吗？
期刊官网编委会页面上标注了国家的 215 位编委中，中国大陆 30 位（约 14%）；人数最多的国家是 美国（76 位）、中国（30 位）、罗马尼亚（16 位）。统计按编委会页面列出的机构国家计，仅供参考。
Journal of Cellular and Molecular Medicine 被哪些数据库收录？
据 LetPub 与 DOAJ 记录，Journal of Cellular and Molecular Medicine 被 SCIE、Scopus、DOAJ 收录。期刊官网自述还被 Web of Science、MEDLINE、PubMed 收录，该清单未与各数据库逐一核对。
Journal of Cellular and Molecular Medicine 是开放获取期刊吗？版面费多少？
Journal of Cellular and Molecular Medicine 为完全开放获取。APC 约 5,730 美元。
来源与更新
本页事实来自 LetPub、OpenAlex、DOAJ、出版商官网；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-26 归档）。最近更新：。